The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Using the decline in CA19-9 after the start of chemotherapy to predict survival in patients with inoperable bile duct cancer.
Mie Grunnet
No relevant relationships to disclose
Lene Baeksgaard
No relevant relationships to disclose
Inga Laursen
No relevant relationships to disclose
Ulrik Niels Lassen
No relevant relationships to disclose
Morten Sorensen
No relevant relationships to disclose